Table 2.
Plasma amino acids levels in two cohorts according to TG levels.
| LMUFAH | SAHODMU | |||||
|---|---|---|---|---|---|---|
| TG <1.7 mmol/L | TG ≥ 1.7 mmol/L | q | TG <1.7 mmol/L | TG ≥ 1.7 mmol/L | q | |
| Ala, μmol/L | 119.70 ± 37.28 | 136.70 ± 40.31 | 0.0109 | 164.90 ± 50.98 | 185.70 ± 57.04 | 0.0092 |
| Arg, μmol/L | 8.67 (5.24–15.01) | 10.56 (5.77–16.65) | 0.4471 | 3.36 (1.88–4.61) | 2.80 (1.86–4.56) | 0.8663 |
| Asn, μmol/L | 72.23 ± 19.55 | 84.12 ± 24.09 | 0.0219 | 69.60 ± 16.67 | 78.22 ± 25.54 | 0.0029 |
| Asp, μmol/L | 27.59 ± 12.17 | 29.86 ± 10.99 | 0.3966 | 25.79 ± 10.53 | 28.14 ± 12.30 | 0.3157 |
| Cit, μmol/L | 21.19 ± 6.94 | 20.91 ± 7.32 | 0.8926 | 24.67 (20.48–30.63) | 22.17 (17.18–29.75) | 0.0157 |
| Cys, μmol/L | 1.24 ± 0.58 | 1.31 ± 0.58 | 0.5591 | 1.33 (0.80–1.87) | 1.29 (0.85–1.94) | 0.8663 |
| Gln, μmol/L | 6.31 (4.71–8.71) | 7.40 (5.79–9.14) | 0.1734 | 8.50 (5.72–11.06) | 7.97 (5.83–11.02) | 0.8663 |
| Glu, μmol/L | 87.99 (75.81–102.94) | 94.78 (83.50–111.10) | 0.0843 | 129.08 (104.02–157.22) | 129.58 (107.28–153.97) | 0.8663 |
| Gly, μmol/L | 184.30 ± 72.09 | 210.10 ± 80.46 | 0.1592 | 165.10 (141.94–185.09) | 162.88 (144.52–186.65) | 0.3157 |
| Hcy, μmol/L | 7.91 (6.45–8.63) | 7.72 (6.40–8.16) | 0.3291 | 8.57 (8.02–9.27) | 8.48 (8.01–9.17) | 0.8663 |
| His, μmol/L | 41.28 (32.77–66.60) | 47.31 (34.91–77.75) | 0.2578 | 64.27 (42.37–93.25) | 67.07 (42.16–99.20) | 0.7181 |
| Leu, μmol/L | 120.00 ± 39.89 | 145 ± 48.52 | 0.0219 | 111.34 (95.16–126.09) | 122.35 (106.21–148.89) | 0.0023 |
| Lys, μmol/L | 130.30 ± 60.30 | 131.30 ± 59.29 | 0.9194 | 134.32 (99.20–173.80) | 137.53 (86.14–191.94) | 0.8663 |
| Met, μmol/L | 16.47 (13.99–21.43) | 16.37 (14.21–21.10) | 0.6456 | 14.80 ± 3.95 | 14.40 ± 5.14 | 0.8663 |
| Orn, μmol/L | 16.57 (12.44–23.93) | 17.49 (12.95–22.57) | 0.9194 | 11.24 (9.11–14.28) | 11.53 (8.41–14.98) | 0.8751 |
| Phe, μmol/L | 42.62 ± 12.05 | 47.34 ± 11.45 | 0.0823 | 40.38 ± 12.05 | 38.95 ± 11.19 | 0.7181 |
| Pip, μmol/L | 128.37 (98.83–182.87) | 124.67 (92.52–153.26) | 0.3966 | 191.60 ± 76.82 | 194.00 ± 94.09 | 0.8663 |
| Pro, μmol/L | 486.90 ± 178.80 | 520.70 ± 186.90 | 0.3966 | 423.40 ± 153.00 | 496.90 ± 166.20 | 0.0023 |
| Ser, μmol/L | 51.21 (42.53–63.04) | 51.25 (44.69–67.80) | 0.4112 | 45.53 ± 10.59 | 45.11 ± 12.07 | 0.8663 |
| Thr, μmol/L | 23.26 ± 7.18 | 25.46 ± 6.82 | 0.1592 | 24.54 ± 7.59 | 23.97 ± 7.46 | 0.8663 |
| Trp, μmol/L | 44.17 ± 12.47 | 48.39 ± 13.61 | 0.1592 | 39.38 ± 11.21 | 41.78 ± 12.91 | 0.3157 |
| Tyr, μmol/L | 43.86 (34.27–54.65) | 46.71 (38.20–56.51) | 0.2593 | 51.84 ± 15.04 | 52.81 ± 17.29 | 0.8663 |
| Val, μmol/L | 129.70 ± 33.28 | 147.20 ± 36.53 | 0.0284 | 141.60 ± 32.37 | 157.50 ± 43.92 | 0.0029 |
TG, triglyceride; LMUFAH, Liaoning Medical University First Affiliated Hospital; SAHODMU, the Second affiliated hospital of Dalian Medical University; Ala, aanine; Asn, asparagine; Leu, leucine; Phe, phenylalanine; Trp, tryptophan; Tyr, tyrosine; Val, valine; Arg, arginine; Gly, glycine; Pro, proline; Thr, threonine; Cit, citrulline;Gln, glutamine; His, histidine; Lys, lysine; Met, methionine; Ser, serine; Orn, ornithine; Glu, glutamate; Asp, aspartate; Pip, piperamide, Cys, cysteine; Hcy, homocysteine.
Data are mean ± standard deviation, median (IQR), or n (%).
False discovery rate was calculated for multiple comparisons and q <0.05 was defined as statistically significant.